Panel Discussion: Leadership for the next leap

Panellists in this video:
+ Ms Viveka Roychowdhury, Editor, Express Pharma (MODERATOR)
+ Mr Parag Sancheti, CEO, Rubicon Research
+ Dr Mahesh Bhalgat, Group CEO and MD, Veeda Lifesciences
+ Mr BG Barve, Joint MD, Bluecross Laboratories
+ Mr Prakash Agarwal, President-Strategy, Mankind Pharma
+ Dr Pratik Shah, VP-Medical Affairs, Bharat Serums and Vaccines
+ Dr C Naveen Kumar Reddy, AVP, Head- Project Management-API division, MSN Laboratories
+ Ms Divya Sharma, Sr GM – Strategic Manufacturing Projects, Lupin

Key Highlights:
[1] India must transition from being a high-volume producer to a global leader in value-driven pharma innovation

[2] Collaboration across R&D, manufacturing, distribution, and healthcare systems is essential for driving growth and innovation

[3] With regulatory processes becoming more streamlined, India is poised to witness a significant rise in clinical trials, accelerating drug development

[4] Increased clinical trials will lead to a wider range of medicines becoming available in the Indian market, improving patient outcomes

[5] A stronger synergy between industry and academic institutions will be key to advancing high-quality pharmaceutical innovations

[6] Fostering interest in science and research among young minds is critical to sustaining long-term innovation in the pharma sector

[7] Integrating advanced data analytics, cutting-edge technology, and skilled talent will drive the next phase of growth in India’s pharma industry

[8] Quality and execution are two very important pillars of long term pharma value chain